| # | Drug | Count |
|---|---|---|
| 0 | ALEMTUZUMAB | 7 |
| 1 | ACETAMINOPHEN | 6 |
| 2 | DIPHENHYDRAMINE HYDROCHLORIDE | 6 |
| 3 | ACETAMINOPHEN 500MG | 4 |
| 4 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 4 |
| 5 | CYCLOSPORINE | 4 |
| 6 | LISINOPRIL | 4 |
| 7 | LORAZEPAM | 4 |
| 8 | NIVOLUMAB | 4 |
| 9 | PAIN RELIEVER | 4 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | EQUINE THYMOCYTE IMMUNE GLOBULIN | 1 | 0.0010 |
| 1 | ALEMTUZUMAB | 7 | 0.0004 |
| 2 | DANAZOL | 1 | 0.0004 |
| 3 | ESTROGEN | 1 | 0.0003 |
| 4 | ACLIDINIUM BROMIDE | 2 | 0.0003 |
| 5 | DIMENHYDRINATE | 3 | 0.0003 |
| 6 | EMTRICITABINE, RILPIVIRINE HYDROCHLORIDE, AND TENOFOVIR ALAFENAMIDE | 1 | 0.0003 |
| 7 | LARONIDASE | 1 | 0.0002 |
| 8 | SELENIUM | 1 | 0.0002 |
| 9 | LIOTHYRONINE SODIUM | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 7 | 0.0004 |
| 1 | Insulin-like Growth Factor-1 Receptor Inhibitor [EPC] | 1 | 0.0002 |
| 2 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 3 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | Sulfone [EPC] | 1 | 0.0001 |
| 6 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 7 | Androgen [EPC] | 2 | 0.0001 |
| 8 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 9 | Progesterone [EPC] | 1 | 0.0000 |